Last reviewed · How we verify

NCT06964295

Comparison of First Attempt Success in Nasotracheal Intubation Using Macintosh Videolaryngoscope vs. Flexible Bronchoscope

ENROLLING BY INVITATION NA Last updated 28 January 2026
What this trial tests

NA trial testing Macintosh videolaryngoscope in Intubation Complication in 74 participants. Enrolling by invitation.

Timeline
9 May 2025
Primary endpoint
7 May 2026
7 May 2026

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment74
Start date9 May 2025
Primary completion7 May 2026
Estimated completion7 May 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Intubation Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants are randomly assigned to two groups: one group undergoes nasotracheal intubation using a videolaryngoscope, while the other group undergoes nasotracheal intubation using a flexible bronchoscope. The primary outcome is the first-attempt success rate, assessed at the time of tracheal tube placement. Additional outcomes include the degree of subglottic injury upon extubation, and the incidence and severity of sore throat and hoarseness at 1 hour and 24 hours postoperatively, as well as overall intubation success rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Macintosh videolaryngoscope

Trials testing the same drug.

Other recruiting trials for Intubation Complication

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing